Comparing 4L Golytely to 2L Golytely With 15mg Bisacodyl Regimens for Inpatient Colonic Preparation
- Conditions
- Colonoscopy
- Interventions
- Drug: 2L Golytely/bisacodylDrug: Standard Bowel Prep
- Registration Number
- NCT01452737
- Lead Sponsor
- University of British Columbia
- Brief Summary
The investigators wish to compare the efficacy and patient tolerability of a preparation consisting of 2L Golytely (PEG + electrolytes) plus 15mg of bisacodyl vs the standard preparation of 4L Golytely. The investigators hypothesize that 2L Golytely with 15mg bisacodyl will show similar bowel cleansing efficacy while offering better tolerability.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Inpatients undergoing colonoscopy
- Age 19 or over
- Unable to provide informed consent
- Patients with constipation
- Patients with suspected bowel obstruction or severe inflammatory bowel disease
- Same-day colonoscopy
- Intensive/critical care patient
- History of colorectal resection
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2L Golytely/15mg bisacodyl 2L Golytely/bisacodyl Subjects will be asked to take 2L Golytely + 15mg bisacodyl for bowel prep the day before colonoscopy. Standard bowel prep Standard Bowel Prep Subject will receive standard bowel prep (4L Golytely) prior to colonoscopy.
- Primary Outcome Measures
Name Time Method Difference in Boston Bowel Preparation Scale & Ottawa Bowel Preparation Scale between the two groups 30min These are established rating scales to evaluate the quality of bowel prep. The ratings will be compared between the two groups.
- Secondary Outcome Measures
Name Time Method Difference in the absolute number/percentage of participants in the two groups who find the bowel prep experience easy, acceptable, difficult, very difficult, or unable to complete. 20hours Participants will be asked to rate their bowel prep experience (based on ease of use) on a Likert scale. The number of participants in each level will subsequently be quantified (n, %) and compared between the two groups.
Difference in the number of participants who develop distress symptoms from bowel prep (and the type) between the two groups 20hours Number of participants who develop distress symptoms from bowel prep, and the type of distress symptoms will be compared between the two groups
Trial Locations
- Locations (1)
St. Paul's Hospital
🇨🇦Vancouver, British Columbia, Canada